Literature DB >> 10614713

Cell cycle-dependent regulation of the DNA-dependent protein kinase.

A Nilsson1, F Sirzén, R Lewensohn, N Wang, S Skog.   

Abstract

Human DNA-dependent protein kinase (DNA-PK) is a nuclear-localized serine/threonine protein kinase. The holoenzyme consists of a catalytic subunit with a molecular mass of 465 kDa and a DNA-binding heterodimer Ku86/70. The kinase has been implicated in a variety of nuclear processes including V(D)J recombination, double-strand break repair, and transcription. Cells with defective DNA-PK activity show increased radiosensitivity and lack of V(D)J recombination. To study DNA-PK activity during the cell cycle, HeLa cells were separated by elutriation centrifugation into different cell cycle compartments based on cellular size. DNA-PK activity was found to vary during the cell cycle. The kinase activity was lowest during G1 phase and increased dramatically as the cells entered S phase and remained high during the G2-phase. The subcellular distribution of DNA-PKcs is relocalized from the cytoplasm during M and G1 phases to the nucleus during G1-S phase transition and S phase. Expression of both the catalytic subunit and the Ku86/70 heterodimer was found to be constant throughout the cell cycle. This study demonstrates that DNA-PK activity as well as its subcellular localization fluctuates during the cell cycle. In addition, the distribution of DNA-PK during M phase corresponds with low DNA-PK activity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10614713      PMCID: PMC6726331          DOI: 10.1046/j.1365-2184.1999.3240239.x

Source DB:  PubMed          Journal:  Cell Prolif        ISSN: 0960-7722            Impact factor:   6.831


  21 in total

1.  Cell-cycle-regulated phosphorylation of DNA replication factor A from human and yeast cells.

Authors:  S Din; S J Brill; M P Fairman; B Stillman
Journal:  Genes Dev       Date:  1990-06       Impact factor: 11.361

2.  Kinetics of DNA double-strand break repair throughout the cell cycle as assayed by pulsed field gel electrophoresis in CHO cells.

Authors:  L Metzger; G Iliakis
Journal:  Int J Radiat Biol       Date:  1991-06       Impact factor: 2.694

3.  Expression of the Ku protein during cell proliferation.

Authors:  M Yaneva; S Jhiang
Journal:  Biochim Biophys Acta       Date:  1991-10-08

4.  Biochemical and genetic defects in the DNA-dependent protein kinase in murine scid lymphocytes.

Authors:  J S Danska; D P Holland; S Mariathasan; K M Williams; C J Guidos
Journal:  Mol Cell Biol       Date:  1996-10       Impact factor: 4.272

5.  A DNA-activated protein kinase from HeLa cell nuclei.

Authors:  T Carter; I Vancurová; I Sun; W Lou; S DeLeon
Journal:  Mol Cell Biol       Date:  1990-12       Impact factor: 4.272

6.  The human double-stranded DNA-activated protein kinase phosphorylates the 90-kDa heat-shock protein, hsp90 alpha at two NH2-terminal threonine residues.

Authors:  S P Lees-Miller; C W Anderson
Journal:  J Biol Chem       Date:  1989-10-15       Impact factor: 5.157

7.  Expression of the human RAD51 gene during the cell cycle in primary human peripheral blood lymphocytes.

Authors:  J Flygare; F Benson; D Hellgren
Journal:  Biochim Biophys Acta       Date:  1996-07-24

8.  Ku80: product of the XRCC5 gene and its role in DNA repair and V(D)J recombination.

Authors:  G E Taccioli; T M Gottlieb; T Blunt; A Priestley; J Demengeot; R Mizuta; A R Lehmann; F W Alt; S P Jackson; P A Jeggo
Journal:  Science       Date:  1994-09-02       Impact factor: 47.728

9.  Defective DNA-dependent protein kinase activity is linked to V(D)J recombination and DNA repair defects associated with the murine scid mutation.

Authors:  T Blunt; N J Finnie; G E Taccioli; G C Smith; J Demengeot; T M Gottlieb; R Mizuta; A J Varghese; F W Alt; P A Jeggo; S P Jackson
Journal:  Cell       Date:  1995-03-10       Impact factor: 41.582

10.  Absence of autoantigen Ku in mature human neutrophils and human promyelocytic leukemia line (HL-60) cells and lymphocytes undergoing apoptosis.

Authors:  A K Ajmani; M Satoh; E Reap; P L Cohen; W H Reeves
Journal:  J Exp Med       Date:  1995-06-01       Impact factor: 14.307

View more
  7 in total

1.  NHJ-1 Is Required for Canonical Nonhomologous End Joining in Caenorhabditis elegans.

Authors:  Aleksandar Vujin; Steven J Jones; Monique Zetka
Journal:  Genetics       Date:  2020-05-26       Impact factor: 4.562

2.  Activation and autoregulation of DNA-PK from structured single-stranded DNA and coding end hairpins.

Authors:  S Soubeyrand; H Torrance; W Giffin; W Gong; C Schild-Poulter; R J Haché
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-31       Impact factor: 11.205

3.  DNA-PKcs, but not TLR9, is required for activation of Akt by CpG-DNA.

Authors:  Ana-Maria Dragoi; Xiaoying Fu; Stanimir Ivanov; Ping Zhang; Linbo Sheng; Dianqing Wu; Gloria C Li; Wen-Ming Chu
Journal:  EMBO J       Date:  2005-01-27       Impact factor: 11.598

4.  Shwachman-Bodian Diamond syndrome is a multi-functional protein implicated in cellular stress responses.

Authors:  Heather L Ball; Bing Zhang; J Jacob Riches; Rikesh Gandhi; Jing Li; Johanna M Rommens; Jeremy S Myers
Journal:  Hum Mol Genet       Date:  2009-07-14       Impact factor: 6.150

5.  HIV-1 causes CD4 cell death through DNA-dependent protein kinase during viral integration.

Authors:  Arik Cooper; Mayra García; Constantinos Petrovas; Takuya Yamamoto; Richard A Koup; Gary J Nabel
Journal:  Nature       Date:  2013-06-05       Impact factor: 49.962

6.  TIP60 K430 SUMOylation attenuates its interaction with DNA-PKcs in S-phase cells: Facilitating homologous recombination and emerging target for cancer therapy.

Authors:  Shan-Shan Gao; Hua Guan; Shuang Yan; Sai Hu; Man Song; Zong-Pei Guo; Da-Fei Xie; Yike Liu; Xiaodan Liu; Shimeng Zhang; Ping-Kun Zhou
Journal:  Sci Adv       Date:  2020-07-10       Impact factor: 14.136

7.  Additive interaction of gefitinib ('Iressa', ZD1839) and ionising radiation in human tumour cells in vitro.

Authors:  N Giocanti; C Hennequin; D Rouillard; R Defrance; V Favaudon
Journal:  Br J Cancer       Date:  2004-12-13       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.